GrowBlox Sciences, Inc. (GBLX)

logo-2GrowBlox Sciences, Inc is a Las Vegas, Nevada-based solutions provider to medical cannabis cultivators and processors. Currently in development state, this company develops proprietary technologies that it plans to implement in the area with the help of its state-level partners.

The company’s technologies are designed to improve various aspects of the cannabis cultivation and production. First, a foremost product of GrowBlox Sciences is an indoor plant-growing space called the GrowBlox Cannabis Grow Chamber, equipped with climate and environmental controls. Similarly, the company offers the InCUBEator Cannabis Propagation Chamber, also a controlled space that ensures consistency in cannabis cultivation through tissue culture method.

GrowBlox also has a technology for extracting medicinal cannabis compounds. This is called the ConversionLAB, and it is touted to ensure clean extracts because it uses CO2. Finally, for drying and curing marijuana, GrowBlox has the CureBLOX Cannabis Drying System, an algorithm-based technology that controls temperature and humidity and eliminates pathogens.

In addition to providing technologies, GrowBlox Sciences presents itself as one of the leaders in processing licenses. Offering state and local license processing, the company’s specialists cover application requests such as branding, compliance, packaging, sales plans, and security.

GrowBlox Sciences, Inc was founded in 2001 under the name Flagstick Ventures, Inc. In 2004, it changed its name and business to the Diabetic Treatment Centers of America, Inc. It changed again in 2008 to Signature Exploration and Production Corp. Then, in 2014, it finally changed to its current name and business.

GrowBlox Sciences, Inc. is now traded as GBLX in the OTC markets. It has a market cap of USD 22.41 M.

Leaders at GrowBlox include Chairman and CEO Craig M. Ellins, CFO and Chief Accounting Officer Steven W. Weldon, and Chief Science Officer Dr. Andrea Small Howard.

GrowBlox Sciences, Inc.

7251 West Lake Mead Blvd
Suite 300
Las Vegas, NV 89128

Phone: (844) 843-2569
Email: info@gbsciences.com
Website: http://gbsciencesinc.com/


Yahoo! Finance: GBLX News

Latest Financial News for GBLX

GB Sciences Obtains Exclusive License for Patented Oral Thin Film Technology Containing Cannabis and Hemp-Derived Ingredients

GB Sciences Obtains Exclusive License for Patented Oral Thin Film Technology Containing Cannabis and Hemp-Derived Ingredients

GBS Global Biopharma and National Research Council of Canada Begin Preclinical Studies on Chronic-Neuropathic Pain Therapies

OTTAWA, Ontario, May 28, 2019 /PRNewswire/ -- GBS Global Biopharma, Inc. ("GBS Global"), a Canadian-based subsidiary of GB Sciences, Inc. (GBLX), announced preclinical studies on their proprietary chronic-neuropathic pain formulations in collaboration with the National Research Council ("NRC") Canada under the direction of Dr. Lee Ellis at NRC laboratories in Halifax, Nova Scotia. Growing public and government concerns regarding opioid abuse make novel pain treatments a promising field of research and development.

GB Sciences Prepares to Triple Production Capabilities in Its Las Vegas Facility

Positioned to Increase Revenue by Approximately $5.6 Million LAS VEGAS , May 14, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) today announced it is nearing completion of $700,000 in power and water ...

GB Sciences Louisiana Receives All Approvals and Announces the Opening of the Full Tissue Propagation Cannabis Cultivation at LSU Agricultural Center

Increases production and ensures a continuous supply of therapeutic cannabis for Louisiana patients. LAS VEGAS, April 16, 2019 /PRNewswire/ -- GB Sciences, Inc. (GBLX), a partner in GB Sciences Louisiana, LLC, is announcing that all cultivation operations at LSU Agricultural Center are now open. This will allow a continuous harvest for patients by increasing GB Sciences Louisiana's production capacity 500%.

Today: GB Sciences' Use of Controlled Cultivation, Product Formulations and Research Will Be Presented by Dr. Dominick Monaco at Cannabis Conference 2019, As Featured on Cover of Cannabis Business Times

LAS VEGAS, April 2, 2019 /PRNewswire/ -- GB Sciences, Inc. (GBLX) announced that Dr. Dominick Monaco, GB Sciences' Director of Medical Formulations, will be a featured speaker at the Las Vegas Cannabis Conference TODAY, April 2, at 4:40pm. Learn more here.